150 related articles for article (PubMed ID: 31271305)
1.
Zhou J; Yang X; Song P; Wang H; Wang X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2715-2720. PubMed ID: 31271305
[No Abstract] [Full Text] [Related]
2. The role of HOXC6 in prostate cancer development.
Hamid AR; Hoogland AM; Smit F; Jannink S; van Rijt-van de Westerlo C; Jansen CF; van Leenders GJ; Verhaegh GW; Schalken JA
Prostate; 2015 Dec; 75(16):1868-76. PubMed ID: 26310814
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy.
Zeng X; Hu Z; Wang Z; Tao J; Lu T; Yang C; Lee B; Ye Z
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):119-25. PubMed ID: 24418912
[TBL] [Abstract][Full Text] [Related]
6. HOXC6 promotes gastric cancer cell invasion by upregulating the expression of MMP9.
Chen SW; Zhang Q; Xu ZF; Wang HP; Shi Y; Xu F; Zhang WJ; Wang P; Li Y
Mol Med Rep; 2016 Oct; 14(4):3261-8. PubMed ID: 27573865
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2.
Zhou YJ; Yang HQ; Xia W; Cui L; Xu RF; Lu H; Xue Z; Zhang B; Tian ZN; Cao YJ; Xing ZY; Yin S; He XZ
Life Sci; 2017 Dec; 190():7-14. PubMed ID: 28943214
[TBL] [Abstract][Full Text] [Related]
8. The biological functions and mechanism of miR‑212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2.
Zhou Y; Ji Z; Yan W; Zhou Z; Li H
Oncol Rep; 2017 Sep; 38(3):1411-1419. PubMed ID: 28713997
[TBL] [Abstract][Full Text] [Related]
9. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
[TBL] [Abstract][Full Text] [Related]
10. Elevated CISD2 expression predicts poor diagnosis and promotes invasion and migration of prostate cancer cells.
Zhu QQ; Tian L; Li DL; Wu ZH; He YY; Zhang HK
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6597-6604. PubMed ID: 32633348
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of CXCR7 Is Associated with Poor Prognosis of Prostate Cancer.
Yang J; Tang H; Huang J; An H
Med Sci Monit; 2018 Jul; 24():5185-5191. PubMed ID: 30047547
[TBL] [Abstract][Full Text] [Related]
12. Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy.
Guan Y; Wu Y; Liu Y; Ni J; Nong S
Prostate; 2016 Aug; 76(11):986-93. PubMed ID: 27040772
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
Guo J; Wang M; Wang Z; Liu X
PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of the homeobox C6 transcriptional network in prostate cancer.
McCabe CD; Spyropoulos DD; Martin D; Moreno CS
Cancer Res; 2008 Mar; 68(6):1988-96. PubMed ID: 18339881
[TBL] [Abstract][Full Text] [Related]
15. Loss of HOXC6 expression induces apoptosis in prostate cancer cells.
Ramachandran S; Liu P; Young AN; Yin-Goen Q; Lim SD; Laycock N; Amin MB; Carney JK; Marshall FF; Petros JA; Moreno CS
Oncogene; 2005 Jan; 24(1):188-98. PubMed ID: 15637592
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
17. Upregulated Hoxc6 expression is associated with poor survival in gastric cancer patients.
Zhang Q; Jin XS; Yang ZY; Wei M; Liu BY; Gu QL
Neoplasma; 2013; 60(4):439-45. PubMed ID: 23581417
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
19. Silencing homeobox C6 inhibits colorectal cancer cell proliferation.
Ji M; Feng Q; He G; Yang L; Tang W; Lao X; Zhu D; Lin Q; Xu P; Wei Y; Xu J
Oncotarget; 2016 May; 7(20):29216-27. PubMed ID: 27081081
[TBL] [Abstract][Full Text] [Related]
20. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]